VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
MRKR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
MRKRMarker Therapeutics, Inc.
$1.19$20M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksMRKRQuarterly Balance Sheet

Marker Therapeutics, Inc. (MRKR) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Marker Therapeutics, Inc. (MRKR) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

MRKR Balance Sheet

Quarterly statement

MRKR Balance Sheet

Marker Therapeutics, Inc. (MRKR) balance sheet — 27-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Total Current Assets14.59M17.43M19.07M21.73M14.77M16.99M22.02M10.91M11.68M14.09M17.13M19.49M21.96M10.91M16.62M22.42M29.28M31.02M45.98M51.41M
Cash & Short-Term Investments11.33M14.92M16.07M17.59M10.46M13.69M19.19M9M7.8M11.32M15.11M17.47M18.12M6.4M11.78M18.08M25.82M28.64M42.35M48.71M
Cash Only11.33M14.92M16.07M17.59M10.46M13.69M19.19M9M7.8M11.32M15.11M17.47M18.12M6.4M11.78M18.08M25.82M28.64M42.35M48.71M
Short-Term Investments00000000000000000000
Accounts Receivable1.62M1.38M1.37M1.67M1.67M2.46M2.35M744.41K2.49M1.85M1.03M83.31K1.75M2.08M2.4M1.68M627.63K2.19K237243
Days Sales Outstanding---124.59218.37619.4363.1577.25168.95105.3148.38326.67228.44163.5247.41106.2436.250.110.02-
Inventory00000000-1.38M00000000000
Days Inventory Outstanding--------------------
Other Current Assets591.31K1.14M974.8K1.35M1.35M841.29K001.38M917.01K01.93M2.09M0585.84K00181.86K1.15M0
Total Non-Current Assets000000000000017.03M17.8M18.69M23.04M23.94M22.15M20.53M
Property, Plant & Equipment000000000000017.03M17.8M18.69M23.04M23.94M22.15M20.53M
Fixed Asset Turnover-------------0.07x0.04x0.05x0.03x0.04x0.06x-
Goodwill00000000000000000000
Intangible Assets00000000000000000000
Long-Term Investments00000000000000000000
Other Non-Current Assets0000000000000014300000
Total Assets14.59M17.43M19.07M21.73M14.77M16.99M22.02M10.91M11.68M14.09M17.13M19.49M21.96M27.94M34.42M41.11M52.32M54.96M68.14M71.94M
Asset Turnover---0.07x0.05x0.02x0.14x0.17x0.09x0.08x0.06x0.01x0.03x0.04x0.02x0.02x0.01x0.02x0.02x-
Asset Growth %-1.23%2.59%-13.4%99.21%26.49%20.59%28.58%-44.01%-46.82%-49.57%-50.24%-52.6%-58.04%-49.16%-49.48%-42.85%-34.98%-37.81%49.37%48.11%
Total Current Liabilities2.42M3.64M2.27M3.35M4.28M2.5M3.46M3.46M1.97M2.3M3.07M2.78M2.92M5.2M7.78M11.29M13.47M8.21M12.9M8.23M
Accounts Payable1.02M1.5M793.73K951K1.72M1.3M1.07M1.9M1.08M848.03K961K429.1K1.33M2.86M1.1M2.02M1.77M5.02M5.14M2.33M
Days Payables Outstanding-36.31-52.2832.8133.9126.8639.5737.631.9724.4339.5780.2352.8365.8148.51105.55548.05418.95249.52
Short-Term Debt00000000000000000000
Deferred Revenue (Current)591.31K723.14K974.8K1.35M1.35M000000107.53K002.5M5.05M8M181.86K1.15M0
Other Current Liabilities01.06M87.08K48.65K64.87K44.07K86.95K203.34K775.24K1.04M57.19K1.87M980.9K1.22M2.93M2.31M1.57M746.68K3.94M1.47M
Current Ratio6.03x4.79x8.39x6.50x3.45x6.79x6.36x3.15x5.92x6.12x5.57x7.01x7.52x2.10x2.14x1.99x2.17x3.78x3.56x6.25x
Quick Ratio6.03x4.79x8.39x6.50x3.45x6.79x6.36x3.15x6.62x6.12x5.57x7.01x7.52x2.10x2.14x1.99x2.17x3.78x3.56x6.25x
Cash Conversion Cycle--------------------
Total Non-Current Liabilities00000000000006.82M7.04M7.23M10.82M11.04M11.25M11.43M
Long-Term Debt00000000000000000000
Capital Lease Obligations00000000000006.82M7.04M7.23M10.82M11.04M11.25M11.43M
Deferred Tax Liabilities00000000000000000000
Other Non-Current Liabilities00000000000000000000
Total Liabilities2.42M3.64M2.27M3.35M4.28M2.5M3.46M3.46M1.97M2.3M3.07M2.78M2.92M12.03M14.82M18.51M24.29M19.25M24.15M19.66M
Total Debt00000000000007.49M7.62M7.72M11.56M11.72M11.87M12.01M
Net Debt-11.33M-14.92M-16.07M-17.59M-10.46M-13.69M-19.19M-9M-7.8M-11.32M-15.11M-17.47M-18.12M1.09M-4.17M-10.36M-14.26M-16.92M-30.48M-36.69M
Debt / Equity-------------0.47x0.39x0.34x0.41x0.33x0.27x0.23x
Debt / EBITDA--------------------
Net Debt / EBITDA--------------------
Interest Coverage--------------------
Total Equity12.17M13.8M16.8M18.39M10.49M14.49M18.56M7.45M9.7M11.79M14.05M16.71M19.03M15.91M19.6M22.6M28.03M35.71M43.99M52.28M
Equity Growth %15.97%-4.8%-9.49%146.84%8.12%22.93%32.06%-55.41%-49.03%-25.92%-28.31%-26.08%-32.08%-55.43%-55.44%-56.77%-55.68%-50.75%60.86%70.87%
Book Value per Share0.630.711.101.100.751.302.040.831.091.321.581.892.161.822.332.703.354.305.296.29
Total Shareholders' Equity12.17M13.8M16.8M18.39M10.49M14.49M18.56M7.45M9.7M11.79M14.05M16.71M19.03M15.91M19.6M22.6M28.03M35.71M43.99M52.28M
Common Stock16.67K16.67K16.67K16.67K11.31K11.21K10.71K8.92K8.92K8.91K8.89K8.89K8.8K8.8K8.41K83.6K83.6K83.45K83.08K83.08K
Retained Earnings-464.19M-462.36M-459.18M-457.48M-455.48M-451.46M-447.02M-443.18M-440.87M-438.68M-436.29M-433.48M-430.5M-433.02M-428.05M-424.19M-417.27M-408.03M-398.12M-388.36M
Treasury Stock00000000000000000000
Accumulated OCI00000000000000000000
Minority Interest00000000000000000000